Using breast cancer as an example, technologies and workflows will be established that enable the collection of additional molecular patient data beyond existing genomic data. In particular, protein-a
Medical needs Immunotherapies have revolutionized cancer treatment in recent years, but their success is severely limited due to the as yet unpredictable individual response. The high proportion of un
With the Biological Development Center, the NMI Natural and Medical Sciences Institute in Reutlingen, together with the Werner Siemens Imaging Center (WSIC) at the Faculty of Medicine and the Universi
RegioWIN Lighthouse Project LTP3: Research Campus BioMedTech, Project 2: Verbund BioMedTech: System Immunology at Biological-Technical Interfaces Cooperation between science and industry at the interf
Bonding of Nitinol Mixed Compounds Dr. Dagmar Martin Group Leader Interface Analysis in the Production Process +49 7121 51530-863 E-Mail anzeigen In projects of this kind, the bonding of nitinol blend
Despite the low greenhouse effect of CO2, CO2 emissions alone account for the largest share of climate-relevant emissions in Baden-Württemberg due to the quantity emitted. Baden-Württemberg's declared
Bioelectronic Implants Dr. Peter D. Jones Group Leader Biomedical Micro and Nano Engineering +49 7121 51530-800 E-Mail anzeigen Assembly, encapsulation and test engineering of bioelectronic implants B
Development of Microelectrode Arrays Dr. Peter D. Jones Group Leader Biomedical Micro and Nano Engineering +49 7121 51530-800 E-Mail anzeigen Microelectrode Arrays (MEAs) are instrumental in electroph
Degradation and Remodeling of Implant Materials Dr. Julia Marzi Group Leader Biophotonics & Spectroscopy +49 7121 07121 51530-78 E-Mail anzeigen Dr. Hanna Hartmann Head of Biomedicine & Material Scien
Biomarker Detection Dr. Martin Kriebel Molecular and Neurobiology +49 7121 51530-810 E-Mail anzeigen AI-supported diagnosis of tumor-associated drug resistance Late stage cancers have a high tendency
